Dr. Kenneth C. Anderson
Chairman, MMRF Scientific Advisory Board
Chief, Division of Hematologic Neoplasia
Director, James Lipper Multiple Myeloma Center
Kraft Family Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA
www.dfci.harvard.edu
Bart Barlogie, MD
Professor of Medicine and Pathology
Director, Myeloma Institute for Research and Therapy
University of Arkansas for Medical Sciences
Little Rock, AR
www.myeloma.uams.edu
William I. Bensinger, MD
Professor of Medicine
Washington School of Medicine
Fred Hutchinson Cancer Research Center
Seattle, WA
www.fhcrc.org
James Berenson, MD
P Leif Bergsagel, MD, FRCP
Associate Professor of Medicine
Mayo Clinic Cancer Center
Mayo Clinic Scottsdale
Scottsdale, AZ
www.mayoclinic.org
Mario Boccadoro, MD
Professor of Medicine
Director, Section of Hematology
Professor of Medicine
University of Torino
Torino, Italy
www.ematologia.unito.it
William Dalton, PhD, MD
Chief Executive Officer
Center Director
H Lee Moffitt Cancer Center and Research Institute
Tampa, FL
www.moffitt.usf.edu
Meletios A. Dimopoulos, MD
Professor of Therapeutics
University of Athens School of Medicine
Athens, Greece
Philip Greipp, MD
Director, Hemaologic Malignancies Program
Myeloma Disease Group Chair
Section of Hemotology Research
Professor of Medicine, Laboratory Medicine, and Pathology
Mayo Clinic
Rochester, NY
www.mayoclinic.org
Jean-Luc Harousseau, MD
Head of the Hematology Department
Professor of Medicine
University Hospital Nantes
Nantes, France
www.sante.univ-nantes.fr
Mohamad A Hussein, MD
Sundar Jagannath, MD
Chief, Multiple Myeloma and Stem Cell Transplant
Professor of Medicine
St Vincent's Comprehensive Cancer Center
New York, NY
www.svccc.com
Douglas Edgar Joshua, MD, Dphil
Director, Haemotology Services
Central Sydney Area Health Service
Director, Myeloma Research Unit
Royal Prince Alfred Hospital
Sydney, Australia
www.sydneycancer.com.au
Thomas J. Kipps, MD, PhD
Evelyn and Edwin Tasch Chair in Cancer Research
Professor of Medicine, Division of Hematology/Oncology
Deputy Director for Research Operations, Moores UCSD Cancer Center University of California
San Diego School of Medicine
San Diego, CA
www.cancer.ucsd.edu
Kenneth Nilsson, MD
Professor of Cell Pathology
Department of Genetics and Pathology
Uppsala University
Uppsala, Sweden
www.genpat.uu.se
Stephen D. Nimer, MD
G. David Roodman, MD, PhD
Professor of Medicine
Vice Chair for Research
Director, Myeloma Program at UPMC
University of Pittsburgh
Pittsburgh, PA
Steve Rosen, MD, FACP
Director, Robert H. Lurie Comprehensive Cancer Center
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, IL
www.cancer.northwestern.edu
Jesus F. San-Miguel, MD, PhD
Head of the Hematology Department
Professor of Medicine
Vice Director of CIC
Hospital Universitario de Salamanca and Centro de Investigaciondel Cancer (CIC)
Univeristy of Salamanca
Salamanca, Spain
www.cicancer.org
Pieter Sonneveld, MD
Louis M. Staudt, MD, PhD
Chief, Lymphoidic Malignancies Section
Metabolism Branch, Center for Cancer Research
National Cancer Institute
Bethesda, MD
www.ccr.cancer.gov
Freda K. Stevenson, MSc, Dphil, FRCP
Professor
University of Southampton School of Medicine
Southampton, United Kingdom
www.som.soton.ac.uk
Keith Stewart, MD, ChB
Donna M. Weber, MD
Associate Professor
Department of Lymphoma and Myeloma
MD Anderson Cancer Center
Houston, TX
www.mdanderson.org